Product Usage: This product is intended for research purposes only.
All product information available on this website is for educational purposes only. Any form of bodily introduction into humans or animals is strictly prohibited by law. This product should only be handled by licensed and qualified professionals. It is not a drug, food, or cosmetic, and must not be misbranded, misused, or mislabeled as such.
BPC-157 (0.5mg/capsule), 60 Capsules
During our packaging transition, you may receive products with either our previous or updated label. Rest assured, the formulation, purity and quality remain exactly same as standards.
BPC-157 is a synthetic 15-amino-acid pentadecapeptide studied for its interactions with signaling pathways associated with angiogenesis, extracellular matrix regulation, and cellular migration. Experimental investigations have reported effects on VEGFR2 phosphorylation, focal adhesion kinase (FAK) activation, ERK1/2 signaling, and nitric oxide-associated regulatory pathways. These observations have made BPC-157 a useful research tool for examining peptide-mediated signal transduction, cytoskeletal organization, extracellular matrix dynamics, and the coordination of complex cellular signaling networks.
- High Purity – 99% Purity Guaranteed
- Independently Lab Tested
- Research Grade Quality
- For Laboratory Research Use Only
| Chemical Formula | C62H98N16O22 |
|---|---|
| Synonyms | Body Protection Compound 15, Bepecin, L-Valine, glycyl-L-alpha-glutamyl-L-prolyl-L-prolyl-L-prolylglycyl-L-lysyl-L-prolyl-L-alanyl-L-alpha-aspartyl-L-alpha-aspartyl-L-alanylglycyl-L-leucyl- |
| Molar Mass | 1,419.5 g/mol |
| CAS Number | 137525-51-0 |
| PubChem CID | |
| Total Compound Content | 30 mg (0.5 mg per capsule) |
| Shelf Life | 36 months |
Every batch is independently lab tested for identity, purity and potency. View our lab testing program →
Does formulation format alter the underlying pharmacological properties of BPC-157?
The biochemical and structural characteristics of BPC-157 are determined by the peptide itself rather than its formulation format. Research involving BPC-157 focuses on its interactions with signaling pathways such as VEGFR2, FAK, ERK1/2, and nitric oxide-associated regulatory networks. Comparative investigations may evaluate formulation-specific variables, but the underlying peptide sequence and molecular properties remain unchanged.
Why is BPC-157 considered a comparatively stable peptide in experimental research?
BPC-157 contains multiple proline-rich motifs that are believed to contribute to resistance against enzymatic degradation under a range of experimental conditions. This stability profile distinguishes it from many peptide-based research compounds and has contributed to interest in its biochemical persistence, signaling activity, and pathway-specific effects in mechanistic investigations.
What makes BPC-157 a useful tool for signaling pathway research?
Experimental investigations have reported interactions with VEGFR2 phosphorylation, focal adhesion kinase (FAK) activation, ERK1/2 signaling, nitric oxide-associated pathways, and extracellular matrix regulatory networks. These characteristics make BPC-157 a valuable research tool for studying peptide-mediated signal transduction, cellular migration processes, cytoskeletal organization, and extracellular matrix dynamics.
-
-
-
-
-
SALE
-
-
-
